Deep sequencing as a diagnostic tool in patients with suspected primary vitreoretinal lymphoma.

MDS detected pathogenic mutations in five out of six patients diagnosed with VRL, including in two patients with negative cytology, demonstrating its potential to improve diagnostic rates of VRL as an adjunctive test.